Overweight S&P Biotech
Publicado en
We doubt the merger mania is over and we continue to believe that more mega deals are in store, either intra or inter-industry, with Big Pharma hungry and in a hurry to replenish their drug pipeline. From a long-term macro perspective, biotech stocks have…
¿Interesado en leer el Daily Insight completo?
Lee el análisis completo con acceso instantáneo.
Investigación BCA | Essentials
Concise macro insight that cuts through daily noise, helping clients stay informed on what matters in markets, why it matters, and how to talk about it, without spending hours reading research.
Mantente conectado con BCA
Recibe nuestros últimos eventos y análisis de investigación directamente en tu correo.